Correlation Between BioNTech and Structure Therapeutics

Can any of the company-specific risk be diversified away by investing in both BioNTech and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioNTech SE and Structure Therapeutics American, you can compare the effects of market volatilities on BioNTech and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Structure Therapeutics.

Diversification Opportunities for BioNTech and Structure Therapeutics

-0.74

Correlation Coefficient

BioNTech  Structure Therapeutics

Pay attention - limited upside

The 3 months correlation between BioNTech and Structure is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of BioNTech i.e., BioNTech and Structure Therapeutics go up and down completely randomly.

Pair Corralation between BioNTech and Structure Therapeutics

Given the investment horizon of 90 days BioNTech SE is expected to generate 1.12 times more return on investment than Structure Therapeutics. However, BioNTech is 1.12 times more volatile than Structure Therapeutics American. It trades about 0.06 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.2 per unit of risk. If you would invest  10,415  in BioNTech SE on April 30, 2025 and sell it today you would earn a total of  864.00  from holding BioNTech SE or generate 8.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.39%
Values	Daily Returns

BioNTech SE  vs.  Structure Therapeutics America

BioNTech SE

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Structure Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Structure Therapeutics American has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in August 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with BioNTech and Structure Therapeutics

The main advantage of trading using opposite BioNTech and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.

The idea behind BioNTech SE and Structure Therapeutics American pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.